4,7,10-Trioxa-1,13-tridecanediamine
CAS: 4246-51-9
Ref. 3D-FT156587
1kg | Descontinuado | ||
50g | Descontinuado | ||
100g | Descontinuado | ||
250g | Descontinuado | ||
500g | Descontinuado |
Informação sobre produto
- 1,13-Diamino-4,7,10-trioxatridecane
- 1-Propanamine, 3,3′-[oxybis(2,1-ethanediyloxy)]bis-
- 3,3'-[Oxybis(Ethane-2,1-Diyloxy)]Dipropan-1-Amine
- 3,3'-[Oxybis(Ethane-2,1-Diyloxy)]Dipropan-1-Aminium
- 3,3-Oxybis(Ethyleneoxy)Bis(Propylamine)
- 3,3′-((Oxybis(ethane-2,1-diyl))bis(oxy))bis(propan-1-amine)
- 3,3′-[Oxybis(2,1-ethanediyloxy)]bis[1-propanamine]
- 3-[2-[2-(3-Aminopropoxy)ethoxy]ethoxy]propan-1-amine
- 4,7,10-Trioxa-1,13-tridecanamine
- 4,7,10-Trioxatridecane-1,13-diamine
- Ver mais sinónimos
- Ancamine 1922
- Ancamine 1922A
- Bis[2-(3-aminopropoxy)ethyl] ether
- Di(3-Aminopropyl)Digol
- Diethylene glycol bis(3-aminopropyl) ether
- Dpa-Deg
- O,O′-Bis(3-aminopropyl)diethylene glycol
- Propylamine, 3,3′-[oxybis(ethyleneoxy)]bis-
- Q 19262
4,7,10-Trioxa-1,13-tridecanediamine is a biologically active molecule that is known for its ability to inhibit mitochondrial membrane potential and induce apoptosis in tumor cells. It has been shown to be active against human breast cancer cells. The compound also inhibits the growth of bacteria by binding to DNA and preventing transcription and replication. This drug binds to the hydroxyl groups on the surface of the bacterial cell wall, which leads to loss of cell viability. 4,7,10-Trioxa-1,13-tridecanediamine has been shown to have an anti-inflammatory effect when taken orally as well as a cytotoxic effect on tumor cells.